Revised national tuberculosis control programme in India has limited co-hort-wise information about what happens to patients diagnosed with multidrug resistant TB (MDR-TB). We determined the pre-treatment loss to follow-up (non-initiation of treatment by programme within 6 months of diagnosis) and time from diagnosis to treatment initiation in Bhopal district, central India (2014). Pre-treatment loss to follow-up was 13% (0.95 CI: 7%, 23%), not significantly different from the national estimates (18%) and median time to initiate treatment was seven days, lower than that reported elsewhere in the country. Bhopal was performing well with reference to time to treatment initiation in programmatic settings.
References
[1]
Revised National Tuberculosis Control Programme (RNTCP) (2017) TB India 2017. An-nual Status Report. New Delhi.
[2]
World Health Organization (WHO) (20176) Global Tuberculosis Report 2016. Geneva.
[3]
Shewade, H.D., Kokane, A.M., Singh, A.R., Verma, M., Parmar, M., Chauhan, A., et al. (2017) High Pre-Diagnosis Attrition among Patients with Presumptive MDR-TB: An Operational Research from Bhopal District, India. BMC Health Services Research, 17, 249.
[4]
Government of India. Ministry of Home Affairs. Office of Registrar General and Census Commissioner. (2011) Census of India.
http://www.censusindia.gov.in/2011-common/census_2011.html
[5]
Central TB Division. Directorate General of Health Services. Ministry of Health & Family Welfare. Government of India. (2012) Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. New Delhi.
[6]
Singla, N., Satyanarayana, S., Sachdeva, K.S., Van den Bergh, R., Reid, T., Tayler- Smith, K., et al. (2014) Impact of Introducing the Line Probe Assay on time to Treatment Initiation of MDR-TB in Delhi, India. PLoS One, 9, e102989.
[7]
Nair, D., Navneethapandian, P.D., Tripathy, J.P., Harries, A.D., Klinton, J.S., Watson, B., et al. (2016) Impact of Rapid Molecular Diagnostic Tests on Time to Treatment Initiation and Outcomes in Patients with Multidrug-Resistant Tuberculosis, Tamil Nadu, India. Transactions of The Royal Society of Tropical Medicine and Hygiene, 110, 534-541. https://doi.org/10.1093/trstmh/trw060
[8]
Shewade, H.D., Govindarajan, S., Thekkur, P., Palanivel, C., Muthaiah, M., Kumar, A.M.V., et al. (2016) MDR-TB in Puducherry, India: Reduction in Attrition and Turnaround Time in the Diagnosis and Treatment Pathway. Public Health Action, 6, 242–246. https://doi.org/10.5588/pha.16.0075
